血塞通注射液联合常规疗法治疗脑梗死的临床观察

目的 观察血塞通注射液联合常规疗法治疗脑梗死的临床疗效.方法 将122例脑梗死患者随机分为治疗组(62例)和对照组(60例),两组均给予常规综合治疗(胞二磷胆碱静滴,口服肠溶阿司匹林片、都可喜、维生素等)和对症支持治疗,治疗组加用血塞通注射液(主要组分为三七总皂苷)400 mg,每天1次,共治疗14 d.结果 治疗组神...

Clinical observation of Xuesaitong Injection combined with conventional treatment on patients with cerebral infarction

Objective To explore the clinical efficacy of Xuesaitong Injection combined with the conventional treatment in the treatment of cerebral infarction. Methods One hundred and twenty two patients were randomly divieded into treatment (62 patients) and control (60 patients) group, routine combined therapy (Cytidine Diphosphate Choline, enteric coated Aspirin, Duxil, and Vitamins) and support therapy were offered for all patients in both groups, and patients in treatment group received additional Xuesaitong Injection (major component group is Panax notoginseng saponins) 400 mg, once daily for 14 d. Results Neurological function improvement of patients in the treatment was better than that in control group, total effective rates was 93.5% in treatment group, and was significant higher than that in control group (75%). Conclusion Xuesaitong Injection combined with the conventional treatment can effectively improve the neurological function improvement of patients with cerebral infarction and enhance the clinical efficacy.